Literature DB >> 18324474

Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.

Yan Wu1, Yuqin Qiu, Suohui Zhang, Guangjiong Qin, Yunhua Gao.   

Abstract

There is a significant interest in the application of microneedles in intradermal drug delivery systems. Previous studies have demonstrated that skin permeation of drugs can be increased by orders of magnitude with microneedle insertion. In this study, emphasis is placed on the development of low cost, painless intradermal microneedle systems that can enhance the percutaneous drug permeation. Microneedles of octagonal pyramidal shape with the length of 150 mum were employed, and the capabilities of skin permeation enhancement under different delivery conditions were examined. The delivery parameters taken into account included the insertion time and the area of insertion. It was found that when solid microneedle arrays of 150 mum in length were pierced into human dermatomed skin for 5 to 60 s, microconduits with the depth of 50 to 80 mum were created to facilitate the percutaneous permeation of drugs. In percutaneous tests, it was demonstrated that the permeability coefficient of calcein (MW = 622.55) was significantly increased by 10(4) to 10(5) times compared to that on intact skin. In terms of biocompatibility, biological evaluation indicated a broad spectrum of safety for the microneedle system. These results suggest that the octagonal pyramidal microneedles can be an effective tool in developing novel intradermal drug delivery system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324474     DOI: 10.1007/s10544-008-9171-x

Source DB:  PubMed          Journal:  Biomed Microdevices        ISSN: 1387-2176            Impact factor:   2.838


  9 in total

1.  Enhanced bioavailability of L-carnitine after painless intradermal delivery vs. oral administration in rats.

Authors:  Suohui Zhang; Guangjiong Qin; Yan Wu; Yunhua Gao; Yuqin Qiu; Fang Li; Bai Xu
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

2.  Microneedle-Mediated Delivery of Copper Peptide Through Skin.

Authors:  Hairui Li; Yong Sheng Jason Low; Hui Ping Chong; Melvin T Zin; Chi-Ying Lee; Bo Li; Melvina Leolukman; Lifeng Kang
Journal:  Pharm Res       Date:  2015-02-19       Impact factor: 4.200

Review 3.  Micro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications.

Authors:  Muhammad Waseem Ashraf; Shahzadi Tayyaba; Nitin Afzulpurkar
Journal:  Int J Mol Sci       Date:  2011-06-07       Impact factor: 5.923

4.  Microneedling dilates the follicular infundibulum and increases transfollicular absorption of liposomal sepia melanin.

Authors:  Gabriel Serrano; Patricia Almudéver; Juan M Serrano; Julio Cortijo; Carmen Faus; Magda Reyes; Inmaculada Expósito; Ana Torrens; Fernando Millán
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-06-26

5.  The effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin.

Authors:  Jessica Stahl; Manfred Kietzmann
Journal:  BMC Vet Res       Date:  2014-06-20       Impact factor: 2.741

6.  Assessment of solid microneedle rollers to enhance transmembrane delivery of doxycycline and inhibition of MMP activity.

Authors:  Abbie Omolu; Maryse Bailly; Richard M Day
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points.

Authors:  Jessica Stahl; Mareike Wohlert; Manfred Kietzmann
Journal:  BMC Pharmacol Toxicol       Date:  2012-08-13       Impact factor: 2.483

8.  Skin needling to enhance depigmenting serum penetration in the treatment of melasma.

Authors:  G Fabbrocini; V De Vita; N Fardella; F Pastore; M C Annunziata; M C Mauriello; A Monfrecola; N Cameli
Journal:  Plast Surg Int       Date:  2011-04-07

9.  Enhancement strategies for transdermal drug delivery systems: current trends and applications.

Authors:  Delly Ramadon; Maeliosa T C McCrudden; Aaron J Courtenay; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2021-01-20       Impact factor: 4.617

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.